Study of Pulmonary Hypertension in Patients with CKD in a Teaching Hospital

Background: Pulmonary hypertension is defined as a mean artery pressure >25 mm Hg and is a serious and progressive complication of chronic kidney disease and end-stage renal disease. Identifying pulmonary arterial hypertension (PAH) can be challenging but is important in this population since management strategizes differ from those for patients with ESKD who donot have PH. Methods: This was an observational cross section study conducted on 85 patients of CKD stage 4 and 5 (based on KDIGO 2012 criteria) admitted to the medicine wards in Mamata academy of medical sciences, bachupally Hyderabad from the year 2022-2023 Results: In our study 35.2 % cases showed no PAH .Mild PAH noted in 23.5% cases , Moderate PAH noted in 36.4% cases and 4.7% showed severe PAH . systolic and diastolic blood pressure with PH showed significant association .Presence of haemodialysis significantly associated with PH. Significant association was seen with age and BMI. Low haemoglobin was also significantly associated with PH. Conclusion: CKD patients have a higher prevalence of pulmonary hypertension. The prevalence of pulmonary hypertension is high in stage 5 CKD patients, and it is also higher in dialysis patients. Funding: Private Foundation Support

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.20249sk8qs6p
Primary Topic
Health and Well-being Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of Pulmonary Hypertension in Patients with CKD in a Teaching Hospital

Geetika Gorrepati
Journal of the American Society of Nephrology
Health and Well-being Studies
article

Study of Pulmonary Hypertension in Patients with CKD in a Teaching Hospital

Geetika Gorrepati
article en

Abstract

Background: Pulmonary hypertension is defined as a mean artery pressure >25 mm Hg and is a serious and progressive complication of chronic kidney disease and end-stage renal disease. Identifying pulmonary arterial hypertension (PAH) can be challenging but is important in this population since management strategizes differ from those for patients with ESKD who donot have PH. Methods: This was an observational cross section study conducted on 85 patients of CKD stage 4 and 5 (based on KDIGO 2012 criteria) admitted to the medicine wards in Mamata academy of medical sciences, bachupally Hyderabad from the year 2022-2023 Results: In our study 35.2 % cases showed no PAH .Mild PAH noted in 23.5% cases , Moderate PAH noted in 36.4% cases and 4.7% showed severe PAH . systolic and diastolic blood pressure with PH showed significant association .Presence of haemodialysis significantly associated with PH. Significant association was seen with age and BMI. Low haemoglobin was also significantly associated with PH. Conclusion: CKD patients have a higher prevalence of pulmonary hypertension. The prevalence of pulmonary hypertension is high in stage 5 CKD patients, and it is also higher in dialysis patients. Funding: Private Foundation Support

Journal of the American Society of NephrologyVol. 35(10S)
Tulane University (US)
Openalex Percentile: Top 73%
Health and Well-being Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.